Gender mix in twins and fetal growth, length of gestation and adult cancer risk

Paediatric and Perinatal Epidemiology

Volumn 19, Issue SUPPL. 1, 2005, Pages 41-47

  Luke, Barbara ^a   Hediger, Mary ^b   Min, Sung Joon ^c   Brown, Morton B ^d   Misiunas, Ruta B ^e   Gonzalez Quintero, Victor Hugo ^a   Nugent, Clark ^e   Witter, Frank R ^f   Newman, Roger B ^g   Hankins, Gary D V ^h   Grainger, David A ⁱ   Macones, George A ^j  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h University of Texas Medical Branch School of Medicine   (United States)

ⁱ UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

AGGRESSION; AUDITORY SYSTEM; BODY SIZE; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MASCULINITY; POSTNATAL DEVELOPMENT; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; VIRILIZATION; VISUAL ACUITY;

ADULT; BIRTH WEIGHT; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; HORMONES; HUMANS; MALE; NEOPLASMS; RISK FACTORS; SEX FACTORS; TWIN STUDIES; TWINS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 20944441247     PISSN: 02695022     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2005.00616.x     Document Type: Conference Paper

References (68)

1. Paneth N, Susser M. Early origin of coronary heart disease (the 'Barker Hypothesis'). British Medical Journal 1995; 310:411-412.
2. Barker DJP. The fetal origins of coronary heart disease. Acta Paediatrica Supplement 1997; 422:78-82.
3. Sayer AA, Cooper C, Barker DJP. Is lifespan determined in utero? Archives of Disease in Childhood 1997; 77:F161-F162.
4. Eriksson JG, Forsén T, Tuomilehto J, Winter PD, Osmond C, Barker DJP. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. British Medical Journal 1999; 318:427-431.
5. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. American Journal of Clinical Nutrition 1999; 69:179-197.
6. Chase HC. Infant mortality and weight at birth: 1960 United States birth cohort. American Journal of Public Health 1969; 59:1618-1628.
7. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstetrics and Gynecology 1982; 59:624-632.
8. Bottoms SF, Paul RH, Mercer BM, MacPherson CA, Caritis SN, Moawad AH, et al. Obstetric determinants of neonatal survival: antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants. American Journal of Obstetrics and Gynecology 1999; 180:665-669.
9. Cogswell ME, Yip R. The influence of fetal and maternal factors on the distribution of birthweight. Seminars in Perinatology 1995; 19:222-240.
10. Hughes IA, Northstone K, Golding J, the ALSPAC Study Team. Reduced birth weight in boys with hypospadias: an index of androgen dysfunction? Archives of Disease in Childhood. Fetal and Neonatal Edition 2002; 87:F150-F151.
11. de Zegher F, Devlieger H, Eeckels R. Fetal growth: boys before girls. Hormone Research 1999; 51:258-259.
12. de Zegher F, Francois I, Boehmer ALM, Saggese G, Muller J, Hiort O, et al. Androgens and fetal growth. Hormone Research 1998; 50:243-244.
13. Pedersen JF. Ultrasound evidence of sexual difference in fetal size in first trimester. British Medical Journal 1980; 281:1253.
14. Martyn CN, Meade TW, Stirling Y, Barker DJP. Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterine growth. British Journal of Haematology 1995; 89:142-146.
15. Barker DJP, Martyn CN, Osmond C, Hales CN, Fall CHD. Growth in utero and serum cholesterol concentrations in adult life. British Medical Journal 1993; 307:1524-1527.
16. Barker DJP, Martyn CN, Osmond C, Wield GA. Abnormal liver growth in utero and death from coronary heart disease. British Medical Journal 1995; 310:703-704.
17. Myers DA, Nathanielsz PW. Biologic basis of term and preterm labor. Clinics in Perinatology 1993; 20:9-28.
18. Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Howe D, et al. Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Endocrine Research 2000; 26:489-504.
19. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP. Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. American Journal of Obstetrics and Gynecology 1990; 162:213-218.
20. McGregor JA, Leff M, Orleans M, Baron A. Fetal gender differences in preterm birth: findings in a North American cohort. American Journal of Perinatology 1992; 9:43-48.
21. Harlow BL, Frigoletto FD, Cramer DW, Evans JK, LeFevre ML, Bain RP, et al. Determinants of preterm delivery in low-risk pregnancies: the RADIUS study group. Journal of Clinical Epidemiology 1996; 49:441-448.
22. Cooperstock M, Campbell J. Excess males in preterm birth: interactions with gestational age, race, and multiple birth. Obstetrics and Gynecology 1996; 88:189-193.
23. Cooperstock MS, Bakewell J, Herman A, Schramm WF. Effects of fetal sex and race on risk of very preterm birth in twins. American Journal of Obstetrics and Gynecology 1998; 179:762-765.
24. Divon MY, Ferber A, Nisell H, Westgren M. Male gender predisposes to prolongation of pregnancy. American Journal of Obstetrics and Gynecology 2002; 187:1081-1083.
25. Steier JA, Myking OL, Ulstein M. Human chorionic gonadotropin in cord blood and peripheral maternal blood in singleton and twin pregnancies at delivery. Acta Obstetricia et Gynecologica Scandinavica 1989; 68:689-692.
26. Steier JA, Myking OL, Bergsjø PB. Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies. Acta Obstetricia et Gynecologica Scandinavica 1999; 78:363-371.
27. Danzer H, Braunstein GD, Rasor J, Forsythe AW. Maternal serum chorionic gonadotropin concentrations and fetal sex prediction. Fertility and Sterility 1984; 34:336-340.
28. Steier JA, Ulstein M, Myking OL. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstetrics and Gynecology 2002; 100:552-556.
29. Min S-J, Luke B, Gillespie B, Min L, Newman RB, Mauldin JG, et al. Birth weight references for twins. American Journal of Obstetrics and Gynecology 2000; 182:1250-1257.
30. Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181:129-133.
31. Glinianaia SV, Skjærven R, Magnus P. Birthweight percentiles by gestational age in multiple births. Acta Obstetricia et Gynecologica Scandinavica 2000; 79:450-458.
32. Smith APM, Ong S, Smith NCS, Campbell D. A prospective longitudinal study of growth velocity in twin pregnancy. Ultrasound in Obstetrics and Gynecology 2001; 18:485-487.
33. Loos RJF, Derom C, Eeckels R, Derom R, Vlietinck R. Length of gestation and birthweight in dizygotic twins. Lancet 2001; 358:560-561.
34. Loos RJF, Derom C, Eeckels R, Derom R, Vlietinck R. Gestation and birthweight in dizygotic twins. Lancet 2002; 359:171-172.
35. Glinianaia SV, Magnus P, Harris JR, Tambs K. Is there a consequence for fetal growth of having an unlike-sexed cohabitant in utero? International Journal of Epidemiology 1998; 27:657-659.
36. Blumrosen E, Goldman RD, Blickstein I. Growth discordance and the effect of a male twin on birth weight of its female co-twin: a population-based study. Journal of Perinatal Medicine 2002; 30:510-513.
37. Orlebeke JF, van Baal CM, Boomsma DI, Neeleman D. Birth weight in opposite sex twins as compared to same sex dizygotic twins. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1993; 50:95-98.
38. James WH. Why are boys more likely to be preterm than girls? Plus other related conundrums in human reproduction. Human Reproduction 2000; 15:2108-2111.
39. James WH. Gestation and birthweight in dizygotic twins. Lancet 2002; 359:171-172.
40. Basso O, Olsen J. Sex ratio and twinning in women with hyperemesis or pre-eclampsia. Epidemiology 2001; 12:747-749.
41. Luke B, Min S-J, Gillespie B, Avni M, Witter FR, Newman RB, et al. The importance of early weight gain in the intrauterine growth and birth weight of twins. American Journal of Obstetrics and Gynecology 1998; 179:1155-1161.
42. Resnick SM, Gottesman II, McGue M. Sensation seeking in opposite-sex twins: an effect of prenatal hormones? Behavior Genetics 1993; 23:323-329.
43. Vierikko E, Pulkkinen L, Kaprio J, Viken R, Rose RJ. Sex differences in genetic and environmental effects on aggression. Aggressive Behavior 2003; 29:55-68.
44. Miller EM. Reported myopia in opposite sex twins: a hormonal hypothesis. Optometry and Visual Sciences 1995; 72:34-36.
45. Miller EM, Martin N. Analysis of the effect of hormones on opposite-sex twin attitudes. Acta Geneticae Medicae et Gemellologiae 1995; 44:41-52.
46. McFadden D. A masculinizing effect on the auditory systems of human females having male co-twins. Proceedings of the National Academy of Sciences USA 1993; 90:11900-11904.
47. Boklage CE. Interactions between opposite-sex dizygotic fetuses and the assumptions of Weinberg difference method epidemiology. American Journal of Human Genetics 1985; 37:591-605.
48. Cerhan JR, Kushi LH, Olson JE, Rich SS, Zheng W, Folsom AR, et al. Twinship and risk of postmenopausal breast cancer. Journal of the National Cancer Institute 2000; 92:261-265.
49. Pietiläinen KH, Kaprio J, Räsänen M, Winter T, Rissanen A, Rose RJ. Tracking of body size from birth to late adolescence: contributions of birth length, birth weight, duration of gestation, parent's size, and twinship. American Journal of Epidemiology 2001; 154:21-29.
50. Kaijser M, Lichtenstein P, Granath F, Erlandsson G, Cnattingius S, Ekbom A. In utero exposures and breast cancer: a study of opposite-sexed twins. Journal of the National Cancer Institute 2001; 93:60-62.
51. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990; 335:939-940.
52. Sanderson M, Williams MA, Daling JR, Holt VL, Malone KE, Self SG, et al. Maternal factors and breast cancer risk among young women. Paediatric and Perinatal Epidemiology 1998; 12:397-407.
53. Ekbom A, Hsieh CC, Lipworth L, Adami HO, Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population-based study. Journal of the National Cancer Institute 1997; 89:71-76.
54. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992; 340:1015-1018.
55. Sedin G, Bergquist C, Lindgren PG. Ovarian hyperstimulation in preterm infants. Pediatric Research 1985; 19:548-552.
56. Mazor M, Hershkovitz R, Chaim W, Levy J, Sharony Y, Leiberman JR, et al. Human preterm birth is associated with systemic and local changes in progesterone/17β-estradiol ratios. American Journal of Obstetrics and Gynecology 1994; 171:231-236.
57. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2002; 11:361-368.
58. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter DJ, et al. Birthweight as a risk factor for breast cancer. Lancet 1996; 348:1542-1546.
59. Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E, et al. Perinatal factors and risk of breast cancer. Epidemiology 1996; 7:34-37.
60. Kappel B, Hansen K, Moller J, Faaborg-Anderson J. Human placental lactogen and dU-estrogen levels in normal twin pregnancies. Acta Geneticae Medicae et Gemellologiae 1985; 34:59-65.
61. Duff DB, Brown JB. Urinary oestriol excretion in twin pregnancies. Journal of Obstetrics and Gynaecology of the British Commonwealth 1974; 81:695-700.
62. TambyRaja RL, Ratnam SS. Plasma steroid changes in twin pregnancies. Progress in Clinical Biology and Research 1981; 69A:189-195.
63. Braun MM, Ahlbom A, Floderus B, Briton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes and Control 1995; 6:519-524.
64. Hsieh CC, Lan SJ, Ekbom A, Petridou E, Adami HO, Trichopoulos D. Twin membership and breast cancer risk. American Journal of Epidemiology 1992; 136:1321-1326.
65. Swerdlow AJ, De Stavola BL, Floderus B, Holm NV, Kaprio J, Verkasalo PK, et al. Risk factors for breast cancer at young ages in twins: an international population-based study. Journal of the National Cancer Institute 2002; 94:1238-1245.
66. Hardy MJ, Humeida AK, Bahijri SM, Basalamah AH. Late third trimester unconjugated serum oestriol levels in normal and hypertensive pregnancy: relation to birthweight. British Journal of Obstetrics and Gynaecology 1981; 88:976-982.
67. Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995. International Journal of Cancer 1999; 83:743-749.
68. Hemminki K, Li X. Cancer risks in twins: results from the Swedish Family-Cancer Database. International Journal of Cancer 2002; 99:873-878.